Focusing On The Bigger Picture At The EMA
Top Agency Exec Talks Life Beyond Brexit & Coronavirus
In an exclusive interview with the Pink Sheet, the European Medicines Agency’s Tony Humphreys explains the thinking behind the agency’s regulatory science strategy, why the PRIME scheme is to get a boost – and why the need to tackle health threats ranked so low in a stakeholder consultation.
